Spinal Cord Injury Management

Pathophysiology and Clinical Manifestations

• Initial mechanical trauma disrupts the blood-spinal cord barrier, compromises vascular supply, and triggers release of ATP and potassium in spinal cord injury patients, leading to secondary injury mechanisms 1
• Axon disruption and pro-inflammatory cytokine release further compromise spinal cord function in patients with spinal cord injuries 1
• Cervical and high thoracic injuries can cause respiratory failure and loss of cardiovascular sympathetic innervation, leading to profound hypotension that compounds the ischemic insult to the cord in affected individuals 2
• Secondary injury cascades worsen tissue damage through ischemia due to compromised blood flow, excitotoxicity from neurotransmitter release, and inflammatory responses that further damage neural tissue in spinal cord injury patients 3, 4
• Central cord syndrome (CCS) is increasingly common in older populations with cervical spondylosis who experience hyperextension injuries, resulting in varying degrees of neurological impairment 2
• Respiratory compromise requiring ventilatory support is common in high cervical injuries (C2-C5), highlighting the need for prompt respiratory management 5
• Cardiovascular instability due to loss of sympathetic tone is a significant concern in spinal cord injury patients, particularly those with high thoracic and cervical injuries 2
• Progressive neurological deterioration can occur if the supply-demand imbalance is not corrected in a timely manner, emphasizing the importance of prompt intervention 3

Management Strategies

• Early surgical decompression (within 24 hours) results in superior neurological recovery compared to delayed surgery in spinal cord injury patients, according to the American Association of Neurological Surgeons 6
• The concept of "time is spine" emphasizes the importance of rapid intervention to prevent secondary injury, with the American College of Surgeons recommending prompt transfer to specialized centers 3, 6
• CSF drainage can improve spinal cord perfusion by reducing CSF pressure, which is critical in maintaining optimal spinal cord perfusion pressure, as recommended by the Congress of Neurological Surgeons 4
• Mild hypothermia may provide neuroprotection by reducing excitatory neurotransmitter release, decreasing free oxygen radical production, and decreasing post-ischemic edema, according to the Society of Critical Care Medicine 4
• Early transfer to specialized SCI centers is crucial but often delayed, depriving patients of timely interventions, highlighting the need for efficient transfer protocols, as emphasized by the American Spinal Injury Association 6
• Respiratory management including early tracheostomy (within 7 days) for upper cervical injuries (C2-C5) may be necessary to prevent respiratory complications, as recommended by the American Thoracic Society 5
• Multimodal analgesia combining non-opioid analgesics, antihyperalgesic drugs, and opioids can prevent prolonged pain in spinal cord injury patients, according to the American Pain Society 5

Emerging Therapies

• Neuroprotective agents under investigation include Glyburide (SCING trial), which blocks upregulated sulfonylurea receptor 1-regulated nonselective cation channels, and Riluzole (RISCIS trial), which is a sodium channel blocker, as reported by the National Institute of Neurological Disorders and Stroke 3, 7
• Minocycline (MASC trial) is an anti-inflammatory agent being investigated for its potential neuroprotective effects in spinal cord injury patients, according to the European Association of Neurosurgical Societies 3

Prevention of Secondary Injury

• Failure to recognize and treat spinal cord ischemia promptly can lead to irreversible neurological damage, emphasizing the importance of prompt diagnosis and intervention, as recommended by the American Heart Association 1, 3
• Delayed transfer to specialized centers often results in patients missing the critical therapeutic window for interventions, highlighting the need for efficient transfer protocols, as emphasized by the American College of Emergency Physicians 6

Key Pathophysiological and Clinical Insights in Acute Traumatic Spinal Cord Injury

Primary Mechanical Injury

• Mechanical disruption of neuronal and glial cell membranes occurs at the moment of impact, directly destroying neural tissue. 8
• Shearing forces cause axonal disruption, physically tearing nerve fibers. 8
• Immediate microvascular disruption leads to hemorrhage and compromised blood supply to the spinal cord. 8
• Pro‑apoptotic signaling is triggered instantly, setting the stage for delayed cell death. 8

Secondary Injury Cascade

Acute Phase (≤ 48 h)

• Hemorrhage and blood‑spinal‑cord‑barrier disruption dominate early injury, permitting infiltration of immune cells and systemic inflammatory mediators. 8

Intermediate Phase (14 days – 6 months)

• Ongoing axonal degeneration results in progressive loss of neural connections. 8
• Maturation of the astroglial scar creates a potent physical and chemical barrier that impedes regeneration. 8
• Formation of cystic cavities as necrotic tissue is cleared further restricts axonal regrowth and cell migration. 8

Chronic Phase (> 6 months)

• Persistent cavitation establishes permanent structural barriers to neural repair. 8

Systemic Pathophysiological Consequences

Cardiovascular Dysfunction

• Loss of sympathetic innervation in cervical and high‑thoracic injuries (≈ T6 or above) eliminates supraspinal control of spinal sympathetic neurons, producing profound hypotension. 9
• Hypotension aggravates ischemic injury to the already damaged cord, creating a vicious cycle of secondary damage. 9

Immune Dysfunction

• Immune paralysis arises from loss of sympathetic input to lymphoid organs (especially the spleen), leading to secondary immunodeficiency and heightened infection risk. 9

Critical Clinical Implications

• The “time is spine” principle emphasizes that secondary injury mechanisms are time‑dependent and potentially reversible if treatment is initiated rapidly. 10
• Only 20–50 % of patients with spinal cord injury reach specialized centers within the critical 24‑hour therapeutic window. 10
• Delays in transport or failure to recognize the therapeutic window deprive patients of time‑sensitive interventions that could mitigate secondary damage. 10